A review of nanocarrier-based CNS delivery systems

Current Drug Delivery

Volumn 3, Issue 2, 2006, Pages 219-232

  Tiwari, Sandip B ^a   Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Blood brain barrier; CNS drug delivery; Liposomes; Solid lipid nanoparticles; Solid polymeric nanoparticles

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA TOCOPHEROL; AMITRIPTYLINE; AMPHOTERICIN; ANTIOXIDANT; ASCORBIC ACID; CALPASTATIN; CISPLATIN; CITICOLINE; DIAZEPAM; DICLOFENAC; DIMINAZENE ACETURATE; DOXORUBICIN; ETOPOSIDE; GAMMA BUTYROLACTONE GAMMA CARBONYLHISTIDYLPROLINAMIDE CITRATE; HARRINGTONINE; IDARUBICIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LEUPEPTIN; LIPOSOME; LOPERAMIDE; NERVE GROWTH FACTOR; PACLITAXEL; PHENYTOIN; PROTIRELIN; SOLID LIPID NANOPARTICLE; TOBRAMYCIN; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VALPROIC ACID;

BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CAPILLARY; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NANOSTRUCTURES; POLYMERS;

EID: 33646673555     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720106776359230     Document Type: Review

References (122)

1. Kermani, F. CNS Drugs and CNS Markets: A Strategic Guide to CNS Disorders, Markets and Therapies, 1999.http://www. europeanpharmaceutical.com
2. Pardridge, W. M. Brain Drug Targeting: The Future of Brain Drug Development, Cambridge University Press: Cambridge, UK 2001.
3. World Health Organization, The Global Burden of Disease Project. http://www.who.int
4. Kermani, F.; McGuire, S. The Outlook for Central Nervous System Drug Development, 2002. http://www.samedanltd.com/members/archives/EPC/Winter2002/ FaizKermani.htm
5. Begley, D. J. Pharmacol. Ther., 2004, 104, 29-45.
6. Kreuter, J. Adv. Drug Deliv. Rev., 2001, 47, 65-81.
7. Muller, R. H.; Keck, C. M. J. Nanosci. Nanotechnol., 2004, 4, 471-83.
8. Sherwood, L. Human Physiology: From Cells to Systems, Wadsworth Publishing Company: Belmont, UK 1997.
9. Pardridge, W. M. Peptide Drug Delivery to the Brain, Raven Press: New York, NY 1991.
10. Begley, D. J. Acta Paediatr. Suppl., 2003, 92, 83-91.
11. Sherwood, L. Fundamentals of Physiology: A Human Perspective, West Publishing Company: St. Paul, MN 1995.
12. Burke, M.; Langer, R.; Brim, H. Central Nervous System: Drug Delivery to Treat, John Wiley & Sons, Inc.: New York, NY 1999.
13. Tusji, A. The Blood-Brain Barrier and Drug Delivery to the CNS, Marcel Dekker, Inc.: New York, NY 2000.
14. Abbott, N. J.; Romero, I. A. Mol. Med. Today, 1996, 2, 106-113.
15. Schinkel, A. H. Adv. Drug Deliv. Rev., 1999, 36, 179-194.
16. Pardridge, W. M. Pharmacol. Toxicol., 1992, 71, 3-10.
17. Speiser, P. P. Methods Find. Exp. Clin. Pharmacol., 1991, 13, 337-342.
18. Woo, S. Y.; Dilliplane, P.; Rahman, A.; Sinks, L. F. Cancer Drug Deliv., 1983, 1, 59-62.
19. Allen, T. M.; McAllister, L.; Mausolf, S.; Gyorffy, E. Biochem. Biophys. Acta, 1981, 643, 346-362.
20. Casacchia, M.; Meco, G.; Pirro, R.; Di Cesare, E.; Allegro, A.; Cusimano, G.; Marola, W. Int. Pharmacopsychiat., 1982, 17, 274-279.
21. Beaumier, P. L.; Hwang, K. J. Biochim. Biophys Acta, 1983, 731, 23-30.
22. Harsanyi, B. B.; Hilchie, J. C.; Mezei, M. J. Dent. Res., 1986, 65, 1133-1141.
23. Murray, K. D.; McQuillin, A.; Stewart, L.; Etheridge, C. J.; Cooper, R. G.; Miller, A. D.; Gurling, H. M. Gene Ther., 1999, 6, 190-197.
24. Cao, Y. J.; Shibata, T.; Rainov, N. G. Gene Ther., 2002, 9, 415-419.
25. Schnyder, A.; Huwyler, J. Neurorx., 2005, 2, 99-107.
26. Lasic, D. D. Liposomes: From Physics to Applications, Elsevier Science Publishers Raven Press: Amsterdam, The Netherlands 1993.
27. Tokes, Z. A.; St Peteri, A. K.; Todd, J. A. Brain Res. , 1980, 188, 282-286.
28. Anda, T.; Yamashita, H.; Fujita, H. T., Yoshiharu; Shibata, S. Drug Deliv. Syst., 1995, 10, 425-430.
29. Shibata, S.; Ochi, A.; Mori, K. Neurol. Med. Chir. (Tokyo), 1990, 30, 242-245.
30. Mori, N.; Fukatsu, T. Epilepsia, 1992, 33, 994-1000.
31. Chapat, S.; Frey, V.; Claperon, N.; Bouchaud, C.; Puisieux, F.; Couvreur, P.; Rossignol, P.; Delattre, J. Brain Res. Bull., 1991, 26, 339-342.
32. Onodera, H.; Takada, G.; Tada, K.; Desnick, R. J. Tohoku J. Exp. Med., 1983, 140, 1-13.
33. Loeb, C.; Benassi, E.; Besio, G.; Maffini, M.; Tanganelli, P. Neurology, 1982, 32, 1234-1238.
34. Postmes, T. J.; Hukkelhoven, M.; van den Bogaard, A. E.; Halders, S. G.; Coenegracht, J. J. Pharm. Pharmacol., 1980, 32, 722-724.
35. Zhang, X.; Wang, X.; Li, S.; Hou, X. Beijing Daxue Xuebao, Yixueban, 2002, 34, 362-364.
36. Yokota, M.; Tani, E.; Tsubuki, S.; Yamaura, I.; Nakagaki, I.; Hori, S.; Saido, T. C. Brain Res., 1999, 819, 8-14.
37. Wu, H. L.; Weng, G. Y.; Zhou, X. M.; Cheng, D. D. Zhongguo Yao Li Xue Bao, 1993, 14, 176-178.
38. Mehta, S. C.; Olson, J. J.; Lu, D. R. Drug Deliv., 1995, 2, 175-180.
39. Sinha, J.; Das, N.; Basu, M. K. Biomed. Pharmacother., 2001, 55, 264-271.
40. Fresta, M.; Puglisi, G. Pharm. Res., 1999, 16, 1843-1849.
41. Mori, N.; Kurokouchi, A.; Osonoe, K.; Saitoh, H.; Ariga, K.; Suzuki, K.; Iwata, Y. Brain Res., 1995, 703, 184-190.
42. Fresta, M.; Puglisi, G.; Di Giacomo, C.; Russo, A. J. Pharm. Pharmacol., 1994, 46, 974-981.
43. Imaizumi, S.; Woolworth, V.; Fishman, R. A.; Chan, P. H. Stroke, 1990, 21, 1312-1317.
44. Alyautdin, R. N.; Filippov, V. I. Farmakologiya i Toksikologiya (Moscow), 1989, 52, 20-23.
45. Umezawa, F.; Eto, Y. Biochem. Biophys. Res. Commun., 1988, 153, 1038-1044.
46. Wittendorp-Rechenmann, E.; Namer, I. J.; Steibel, J.; Lam, D. C.; Pouliquen, D. J. Trace and Microprobe Techniq., 1998, 16, 523-534.
47. Mora, M.; Sagrista, M. L.; Trombetta, D.; Bonina, F. P.; De Pasquale, A.; Saija, A. Pharm. Res., 2002, 19, 1430-1438.
48. Fresta, M.; Puglisi, G. Int. J. Pharm., 1996, 134, 89-97.
49. Yagi, K. Nippon Rinsho, 1985, 43, 270-273.
50. Osanai, T.; Nagai, Y. Neurochem. Res., 1984, 9, 1407-1416.
51. Visser, C. C.; Stevanovic, S.; Voorwinden, L. H.; van Bloois, L.; Gaillard, P. J.; Danhof, M.; Crommelin, D. J.; de Boer, A. G. Eur. J. Pharm. Sci., 2005, 25, 299-305.
52. Thole, M.; Nobmanna, S.; Huwyler, J.; Bartmann, A.; Fricker, G. J. Drug Target, 2002, 10, 337-344.
53. Siegal, T.; Horowitz, A.; Gabizon, A. J. Neurosurg., 1995, 83, 1029-1037.
54. Zhang, X.; Xie, J.; Li, S.; Wang, X.; Hou, X. J. Drug Target, 2003, 11, 117-122.
55. Xie, Y.; Ye, L.; Zhang, X.; Cui, W.; Lou, J.; Nagai, T.; Hou, X. J. Control Rel., 2005, 105, 106-119.
56. Zhang, Y.; Schlachetzki, F.; Pardridge, W. M. Mol. Ther., 2003, 7, 11-18.
57. Gosk, S.; Vermehren, C.; Storm, G.; Moos, T. J. Cereb. Blood Flow Metab., 2004, 24, 1193-1204.
58. Sauer, I.; Dunay, I. R.; Weisgraber, K.; Bienert, M.; Dathe, M. Biochemist., 2005, 44, 2021-2029.
59. Jiang, C.; Koyabu, N.; Yonemitsu, Y.; Shimazoe, T.; Watanabe, S.; Naito, M.; Tsuruo, T.; Ohtani, H.; Sawada, Y. Hum. Gene Ther., 2003, 14, 1181-1191.
60. Matsuo, H.; Okamura, T.; Chen, J.; Takanaga, H.; Ohtani, H.; Kaneda, Y.; Naito, M.; Tsuruo, T.; Sawada, Y. J. Drug Target, 2000, 8, 207-216.
61. Kakinuma, K.; Tanaka, R.; Takahashi, H.; Sekihara, Y.; Watanabe, M.; Kuroki, M. Int. J. Hyperthermia, 1996, 12, 157-165.
62. Jain, S.; Mishra, V.; Singh, P.; Dubey, P. K.; Saraf, D. K.; Vyas, S. P. Int. J. Pharm., 2003, 261, 43-55.
63. Gomes, I.; Sharma, S. K. J. Clin. Biochemist. Nutrit., 1995, 18, 133-144.
64. Das, N.; Raay, B.; Basu, M. K. Indian. J. Exp. Biol., 1999, 37, 871-875.
65. Gennuso, R.; Spigelman, M. K.; Chinol, M.; Zappulla, R. A.; Nieves, J.; Vallabhajosula, S.; Alberto Paciucci, P.; Goldsmith, S. J.; Holland, J. F. Cancer Invest., 1993, 11, 118-128.
66. Zhao, J.; Tong, L.; Zhang, S.; Li, C.; Tang, C.; Tang, J. Beijing Yike Daxue Xuebao, 1991, 23, 313-315.
67. Rainov, N. G.; Ikeda, K.; Qureshi, N. H.; Grover, S.; Herrlinger, U.; Pechan, P.; Chiocca, E. A.; Breakefield, X. O.; Barnett, F. H. Hum. Gene Ther., 1999, 10, 311-318.
68. Gomes, I.; Sharma, S. K. Neurochem. Res., 2004, 29, 441-446.
69. Schackert, G.; Fan, D.; Nayar, R.; Fidler, I. J. Sel. Cancer Ther., 1989, 5, 73-79.
70. Chekhonin, V. P.; Zhirkov, Y. A.; Gurina, O. I.; Ryabukhin, I. A.; Lebedev, S. V.; Kashparov, I. A.; Blinov, D. V.; Dmitrieva, T. B. Dokl. Biochem. Biophys., 2003, 391, 236-239.
71. Shi, N.; Zhang, Y.; Zhu, C.; Boado, R. J.; Pardridge, W. M. Proc. Natl. Acad. Sci. USA, 2001, 98, 12754-12759.
72. Huwyler, J.; Pardridge, W. M. J. Neurochem., 1998, 70, 883-886.
73. Huwyler, J.; Cerletti, A.; Fricker, G.; Eberle, A. N.; Drewe, J. J. Drug Target, 2002, 10, 73-79.
74. Zhang, X. B.; Yuan, S.; Lei, P. C.; Hou, X. P. Yao Xue Xue Bao, 2004, 39, 292-295.
75. Kreuter, J. Eur. J. Drug Metab. Pharmacokinet., 1994, 19, 253-256.
76. Kreuter, J. J. Nanosci. Nanotechnol., 2004, 4, 484-488.
77. Domb, A. J.; Amselem, S. Antibiotic Delivery Systems for the Treatment of Chronic Bone Infections, John Wiley & Sons Ltd,: Chichester, UK 1994.
78. Olivier, J. C.; Fenart, L.; Chauvet, R.; Pariat, C.; Cecchelli, R.; Couet, W. Pharm. Res., 1999, 16, 1836-1842.
79. Kreuter, J.; Ramge, P.; Petrov, V.; Hamm, S.; Gelperina, S. E.; Engelhardt, B.; Alyautdin, R.; von Briesen, H.; Begley, D. J. Pharm. Res., 2003, 20, 409-416.
80. Alyautdin, R. N.; Petrov, V. E.; Langer, K.; Berthold, A.; Kharkevich, D. A.; Kreuter, J. Pharm. Res., 1997, 14, 325-328.
81. Alyautdin, R. N.; Tezikov, E. B.; Ramge, P.; Kharkevich, D. A.; Begley, D. J.; Kreuter, J. J. Microencapsul., 1998, 15, 67-74.
82. Alyaudtin, R. N.; Reichel, A.; Lobenberg, R.; Ramge, P.; Kreuter, J.; Begley, D. J. J. Drug Target, 2001, 9, 209-221.
83. Calvo, P.; Gouritin, B.; Chacun, H.; Desmaele, D.; D'Angelo, J.; Noel, J. P.; Georgin, D.; Fattal, E.; Andreux, J. P.; Couvreur, P. Pharm. Res., 2001, 18, 1157-1166.
84. Calvo, P.; Gouritin, B.; Brigger, I.; Lasmezas, C.; Deslys, J.; Williams, A.; Andreux, J. P.; Dormont, D.; Couvreur, P. J. Neurosci. Methods, 2001, 111, 151-155.
85. Calvo, P.; Gouritin, B.; Villarroya, H.; Eclancher, F.; Giannavola, C.; Klein, C.; Andreux, J. P.; Couvreur, P. Eur. J. Neurosci., 2002, 15, 1317-1326.
86. Schroeder, U.; Sommerfeld, P.; Sabel, B. A. Peptides, 1998, 19, 777-780.
87. Schroeder, U.; Sommerfeld, P.; Ulrich, S.; Sabel, B. A. J. Pharm. Sci., 1998, 87, 1305-1307.
88. Gulyaev, A. E.; Gelperina, S. E.; Skidan, I. N.; Antropov, A. S.; Kivman, G. Y.; Kreuter, J. Pharm. Res., 1999, 16, 1564-1569.
89. Abdel Wahab, B., A.; Evgenivetch, P., V.; Alyautdin, R. A. The Internet J. Pharmacol., 2005, 3.
90. Darius, J.; Meyer, F. P.; Sabel, B. A.; Schroeder, U. J. Pharm. Pharmacol., 2000, 52, 1043-1047.
91. Borchardt, G.; Audus, K. L.; Shi, F. Int. J. Pharm., 1994, 110, 29-35.
92. Fenart, L.; Casanova, A.; Dehouck, B.; Duhem, C.; Slupek, S.; Cecchelli, R.; Betbeder, D. J. Pharmacol. Exp. Ther., 1999, 291, 1017-1022.
93. Yang, S. C.; Lu, L. F.; Cai, Y.; Zhu, J. B.; Liang, B. W.; Yang, C. Z. J. Control Rel., 1999, 59, 299-307.
94. Fundaro, A.; Cavalli, R.; Bargoni, A.; Vighetto, D.; Zara, G. P.; Gasco, M. R. Pharmacol. Res., 2000, 42, 337-343.
95. Koziara, J. M.; Lockman, P. R.; Allen, D. D.; Mumper, R. J. J. Control Rel., 2004, 99, 259-269.
96. Reddy, L. H.; Sharma, R. K.; Chuttani, K.; Mishra, A. K.; Murthy, R. R. AAPS J., 2004, 6, e23.
97. Lockman P. R.; Oyewumi M. O.; Koziara J. M.; Roder K. E.; Mumper R. J.; Allen D. D. J. Control Rel., 2003, 93, 271-282.
98. Zara, G. P.; Bargoni, A.; Cavalli, R.; Fundaro, A.; Vighetto, D.; Gasco, M. R. J. Pharm. Sci., 2002, 91, 1324-1333.
99. Bargoni, A.; Cavalli, R.; Zara, G. P.; Fundaro, A.; Caputo, O.; Gasco, M. R. Pharmacol. Res., 2001, 43, 497-502.
100. Olbrich, C.; Gessner, A.; Kayser, O.; Muller, R. H. J. Drug Target, 2002, 10, 387-96.
101. Chukwu, K. I.; Shroder, U.; Sommerfeld, P.; Sabel, B. A., Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 1999, pp. 1148-1149.
102. Ueda, M.; Kreuter, J. J. Microencapsul., 1997, 14, 593-605.
103. Schroeder, U.; Schroeder, H.; Sabel, B. A. Life Sci., 2000, 66, 495-502.
104. Schroder, U.; Sabel, B. A. Brain Res., 1996, 710, 121-124.
105. Ramge, P.; Kreuter, J.; Lemmer, B. Chronobiol. Int., 1999, 16, 767-777.
106. Kreuter, J.; Alyautdin, R. N.; Kharkevich, D. A.; Ivanov, A. A. Brain Res., 1995, 674, 171-174.
107. Kreuter, J.; Petrov, V. E.; Kharkevich, D. A.; Alyautdin, R. N. J. Control Rel., 1997, 49, 81-87.
108. Gelperina S.; Smirnova Z., K. A.; Skidan I., B. A.; J., K. Proceedings of 3rd World Meeting APV/APGI: Berlin, 2000, pp. 441-442.
109. Gasco, M. R. Pharmaceut. Technol. Europe, 2001, 13.
110. Peira, E.; Marzola, P.; Podio, V.; Aime, S.; Sbarbati, A.; Gasco, M. R. J. Drug Target, 2003, 11, 19-24.
111. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Pharm. Res., 1999, 16, 751-757.
112. Zara, G. P.; Cavalli, R.; Bargoni, A.; Fundaro, A.; Vighetto, D.; Gasco, M. R. J. Drug Target, 2002, 10, 327-335.
113. Koziara J., M.; Lockman P. R.; Allen D. D.; Mumper R. J. J. Controlled Rel., 2004, 99, 259-269.
114. Alyautdin, R. A.; Gothier, D.; Petrov, V.; Kharkevich, D.; Kreuter, J. Eur. J. Pharm. Biopharm., 1995, 41, 44-48.
115. Kreuter, J.; Shamenkov, D.; Petrov, V.; Ramge, P.; Cychutek, K.; Koch-Brandt, C.; Alyautdin, R. J. Drug Target, 2002, 10, 317-325.
116. Yocum, D. E.; Allard, S.; Cohen, S. B.; Emery, P.; Flipo, R. M.; Goobar, J.; Jayawardena, S.; Job-Deslandre, C.; Jubb, R. W.; Krüger, K.; Lopes A.; B. Manger; Mur, E.; Nygaard, H.; Weiner, S. M.; Rainer, F.; Sack, M. R.; Schiff, M. H.; Schnitzer, T. J.; Trigg, L. B.; Whatmough, I.; Schmidt, A.-G. Rheumatology, 2000, 39, 156-164.
117. Rxlist, The Internet Drug Index, 2005. http://rxlist.com/
118. Jores, K. Lipid Nanodispersions as Drug Carrier Systems: A Physicochemical Characterization, 2004. http://sundoc. bibliothek. uni-halle.de/diss-online/04/04H310/t2.pdf.
119. Dhanikula, A. Safety Assessment of Lipid Excipients - Glycerol Esters, Phospholipids., 2005. http://www.mapageweb. umontreal. ca/leroujea/ Fonctionnement%20interne/techniques/safety.ppt#10.
120. Fabel, K.; Dietrich, J.; Hau, P.; Wismeth, C.; Winner, B.; Przywara, S.; Steinbrecher, A.; Ullrich, W.; Bogdahn, U. Cancer, 2001, 92, 1936-1942.
121. Advectus Life Sciences: Preliminary Results for Pre-Clinical Brain Cancer Trials, 2003.http://www.nanoinvestornews.com/modules. php?name=News&file= article&sid=1427.
122. Inactive Ingredient Search for Approved Drug Products, 2005.http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.